Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Viskase Holdings, Inc. (VISK) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Viskase Holdings, Inc. (VISK), most recent 12 months reported: net loss $13.65M. Latest balance sheet on file: liquid cash $7.91M, total debt $129.4M, net cash -$121.49M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): SCHOLAR ROCK HOLDING CORPORATION · Protara Therapeutics, Inc. · TECTONIC THERAPEUTIC, INC. · Instil Bio, Inc. · Tenaya Therapeutics, Inc. · Tevogen Inc. · Vor Biopharma Inc. · Zura Bio Ltd

Stock screener

Watchlist